Literature DB >> 12690262

Catabolism of aging: is it an inflammatory process?

Ronenn Roubenoff1.   

Abstract

PURPOSE OF REVIEW: Research in the field of sarcopenia is evolving rapidly, and the process is now recognized as an important cause of frailty and morbidity in the elderly. This review focuses on recent developments in the field, especially regarding the role of catabolic stimuli in causing sarcopenia. RECENT
FINDINGS: There is now an impressive body of literature implicating increased interleukin-6 levels in successfully aging adults. New data indicate that high interleukin-6 levels carry a poor prognosis, although it is not clear if the cytokine has primarily a causal or counter-regulatory function. Interleukin-6 and other cytokines could function through direct catabolic effects, or by causing reduced dietary energy intake (the anorexia of aging), or by inducing insulin resistance or lowering growth hormone-insulin-like growth factor-I concentrations. Furthermore, apoptosis has now been linked to sarcopenia, suggesting that an inflammatory signal could trigger loss of muscle cells in the elderly even in the absence of overt inflammatory disease.
SUMMARY: Aging causes loss of many of the anabolic signals to muscle that are present in young adulthood. Recent research suggests that there is also an increase in catabolic signals with age.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12690262     DOI: 10.1097/01.mco.0000068965.34812.62

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  79 in total

1.  Designing Phase II B trials in sarcopenia: the best target population.

Authors:  M Pahor; M Cesari
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

Review 2.  Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?

Authors:  Maurizio Muscaritoli; Simone Lucia; Alessio Molfino; Tommy Cederholm; Filippo Rossi Fanelli
Journal:  Intern Emerg Med       Date:  2012-07-08       Impact factor: 3.397

3.  Muscle and Bone Mass Loss in the Elderly Population: Advances in diagnosis and treatment.

Authors:  Carlos J Padilla Colón; Irma L Molina-Vicenty; María Frontera-Rodríguez; Alejandra García-Ferré; Bernabejoel Ponce Rivera; Gerardo Cintrón-Vélez; Sebastián Frontera-Rodríguez
Journal:  J Biomed (Syd)       Date:  2018

4.  Cross-sectional and longitudinal associations between the active vitamin D metabolite (1,25 dihydroxyvitamin D) and haemoglobin levels in older Australian men: the Concord Health and Ageing in Men Project.

Authors:  Vasant Hirani; Robert G Cumming; Fiona Blyth; Vasi Naganathan; David G Le Couteur; Louise M Waite; David J Handelsman; Markus J Seibel
Journal:  Age (Dordr)       Date:  2015-02-04

5.  25-hydroxyvitamin D, parathyroid hormone, and functional recovery after hip fracture in elderly patients.

Authors:  Marco Di Monaco; Fulvia Vallero; Roberto Di Monaco; Rosa Tappero; Alberto Cavanna
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 6.  Validated treatments and therapeutic perspectives regarding physical activities.

Authors:  Y Rolland; F Pillard
Journal:  J Nutr Health Aging       Date:  2009-10       Impact factor: 4.075

7.  Geographical segregation and IL-6: a marker of chronic inflammation in older adults.

Authors:  Jama L Purser; Maragatha N Kuchibhatla; Marie L Miranda; Dan G Blazer; Harvey J Cohen; Gerda G Fillenbaum
Journal:  Biomark Med       Date:  2008       Impact factor: 2.851

8.  sTNFR-1 is an early inflammatory marker in community versus institutionalized elderly women.

Authors:  Fernanda Matos Coelho; F M S Narciso; D M G Oliveira; D S Pereira; A L Teixeira; M M Teixeira; D G Souza; L S M Pereira
Journal:  Inflamm Res       Date:  2009-08-22       Impact factor: 4.575

Review 9.  Oxidative stress, molecular inflammation and sarcopenia.

Authors:  Si-Jin Meng; Long-Jiang Yu
Journal:  Int J Mol Sci       Date:  2010-04-12       Impact factor: 5.923

10.  The effects of a muscle resistance program on the functional capacity, knee extensor muscle strength and plasma levels of IL-6 and TNF-alpha in pre-frail elderly women: a randomized crossover clinical trial--a study protocol.

Authors:  Lygia P Lustosa; Fernanda M Coelho; Juscelio P Silva; Daniele S Pereira; Adriana N Parentoni; João M D Dias; Rosangela C Dias; Leani S M Pereira
Journal:  Trials       Date:  2010-07-28       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.